Foresee Pharmaceuticals Co., Ltd. announced a private placement of 78,410 common shares at a price of $100 per share for the gross proceeds of $7,841,000 on may 3, 2024. The transaction has been approved by the shareholders of the company.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
94.2 TWD | 0.00% | +0.21% | -2.08% |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-2.08% | 396M | |
+64.92% | 62.59B | |
-1.85% | 41.18B | |
+44.76% | 40.29B | |
-8.93% | 27.9B | |
+13.05% | 26.21B | |
-21.96% | 19.09B | |
+4.21% | 13.08B | |
+25.74% | 12.26B | |
+27.42% | 12.05B |
- Stock Market
- Equities
- 6576 Stock
- News Foresee Pharmaceuticals Co., Ltd.
- Foresee Pharmaceuticals Co., Ltd. announced that it expects to receive $7.841 million in funding